targeting&#32

2 trials

Sponsors

Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Nanfang Hospital, Southern Medical University

Conditions

Tumorslung cancer

Early Phase 1

Clinical application of PET / CT imaging targeting tumor associated fibroblast activating protein (FAP) in solid tumors

Active, not recruitingChiCTR2000039099

Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyTumors

Start: 2020-10-19Updated: 2021-01-18

A PET/CT clinical trial targeting fibroblast activated protein

RecruitingChiCTR2100045757

Nanfang Hospital, Southern Medical Universitylung cancer

Start: 2020-09-07Updated: 2021-12-06

Related Papers

Performance of [<sup>68</sup>Ga]Ga-FAPI-04 PET/CT imaging in hepatic vascular-associated mesenchymal tumor: comparison with [<sup>18</sup>F]FDG PET/CT.

2025-07-24

Assessment of viable tumours by [<sup>68</sup>Ga]Ga-FAPI-04 PET/CT after local regional treatment in patients with hepatocellular carcinoma.

2025-01-203 citations

[<sup>18</sup>F]F-FAPI-42 PET dynamic imaging characteristics and multiparametric quantification of lung cancer: an exploratory study using uEXPLORER PET/CT.

2025-01-062 citations

[<sup>18</sup>F]FAPI-42 PET imaging in cancer patients: optimal acquisition time, biodistribution, and comparison with [<sup>68</sup>Ga]Ga-FAPI-04.

2021-12-1178 citations